Loading organizations...
Quilt Health offers a digital platform streamlining care coordination and accelerating access to novel therapies for complex conditions. Its technology integrates clinical research with patient care, leveraging clinician and patient networks to improve trial efficiency. The platform facilitates communication across clinics, communities, and home settings, reducing fragmentation for chronic illness management.
Co-founded by Daniel Tatar in 2024, Quilt Health emerged from the insight into significant friction and fragmentation patients and providers face navigating complex conditions. This prompted a digital solution to bridge systemic gaps, connecting disparate healthcare ecosystem components for comprehensive disease management.
Quilt Health serves care teams, patient advocates, and life sciences organizations, with an initial focus on sickle cell disease patients and caregivers. The company envisions a seamless healthcare system for complex conditions, ensuring equitable access to leading care, advanced treatments, and critical clinical trials. This forward-looking vision aims to significantly improve patient outcomes.
Quilt Health has raised $6.0M across 1 funding round.
Quilt Health has raised $6.0M in total across 1 funding round.
Quilt Health has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in June 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2025 | $6M Seed | — | MAC Venture Capital, Underscore VC, Ethan Austin | Announced |
Quilt Health has raised $6.0M in total across 1 funding round.
Quilt Health's investors include MaC Venture Capital, Underscore VC, Ethan Austin.
Quilt Health is a Boston-based digital health technology company founded in 2024 that builds a platform to streamline care coordination, clinical research, and trial access for patients with complex conditions, starting with sickle cell disease (SCD), the most common rare disease in the U.S. affecting around 100,000 people.[2][4][6] It serves hospitals, health systems, clinicians, researchers, patients, caregivers, and life sciences companies by integrating fragmented data sources—like EHRs, labs, and medication histories—applying AI to unstructured clinical data, and providing patient engagement tools to connect clinic, community, and home, ultimately accelerating access to novel therapies and improving trial enrollment, diversity, retention, and efficiency amid challenges like 70% of trials failing recruitment targets.[1][2][3] The company secured $6M in seed funding co-led by Underscore VC, fueling product development, R&D, team expansion, and partnerships with networks like the National Alliance of Sickle Cell Centers (NASCC) in underserved regions.[1][2][4]
Quilt Health was founded in 2024 by CEO Andy (last name not specified in sources) and Co-Founder/Chief of Staff Jazmine Coleman, who brings expertise from health plans, clinical business development, and health equity, giving the team deep insight into clinical care and research environments.[1][2][6] The idea emerged from observing longstanding inefficiencies in bridging research and real-world care for complex diseases, particularly SCD, where fragmented data and coordination gaps hinder providers, patients, and trials; Underscore VC first met Andy nearly a year before their investment (around early 2024) via a community introduction, witnessing the evolution from concept to a strategic AI-powered platform.[1] Early traction includes a partnership with NASCC, comprising 120 sickle cell centers, announced alongside the seed funding to enhance care quality and access using purpose-built tech.[2][4]
Quilt Health rides the wave of AI-enabled digital health transformation, addressing clinical trial failures (70% miss recruitment), data fragmentation in complex care, and inequities in rare disease access—exacerbated for SCD in African, Middle Eastern, and Mediterranean populations—amid tailwinds like FDA pathways for novel therapies.[1][2] Its timing aligns with booming demand for real-world evidence, diverse trials, and integrated care-research platforms, as life sciences seek efficiency and providers tackle coordination burdens in fragmented U.S. healthcare.[3] By partnering with community networks like NASCC in underinvested areas, Quilt influences the ecosystem by democratizing innovation, boosting trial diversity/retention, and translating research into equitable outcomes for millions with complex conditions.[1][4]
Quilt Health is poised to scale its platform beyond SCD into broader hematologic, neurological, and cardiovascular arenas, prioritizing health system partnerships in underserved regions, R&D acceleration, and team growth with fresh $6M seed capital.[1][2] Trends like AI advancements in healthcare data, regulatory support for rare therapies, and emphasis on trial diversity will propel its momentum, potentially positioning it as connective tissue for fragmented complex care ecosystems. Its influence could evolve by setting standards for equitable access, drawing more pharma collaborations, and expanding to post-market surveillance, ultimately stitching innovation into everyday lives for high-need patients—echoing its mission to make transformative care an expectation, not a hope.[1][3]
